About this trial
The goal of this clinical trial is to determine if a standardized 12-point acupuncture protocol will reduce pain in participants with stable angina.
This study addresses the critical need to reduce persistent pain for angina. The investigators long-term goal is symptom management for diverse women and men with angina, targeting additional angina burden borne of social disadvantage
Participants will be randomized to a 10-acupuncture session protocol, two treatments per week for five weeks, or an attention control group. Participants will view designated, non-pain related Technology, Entertainment, Design Talks equal to the time spent receiving acupuncture (\~7.5-10 hrs.).
The investigators will test the efficacy of acupuncture for stable angina/chest pain syndrome to reduce pain and symptoms, improve health-related quality of life, reduce healthcare utilization and and improve patient related health outcomes.
Eligibility criteria
Qualifiers
Diagnosis of stable angina or chest pain syndrome for at least 1 month (pain, pressure, or discomfort in the chest or other areas of the upper body)
Treated with medical therapy for at least 1 month
Experiencing symptoms at least once per week
Speak and read English
Disqualifiers
Pregnancy as some acupuncture points included in the protocol are contraindicated in pregnancy
Physical or cognitive limitations that will prevent informed consent or completion of study tasks
Use of steroid or prescription analgesic medications
Concomitant biofeedback, professional massage and acupuncture.
Trial design
Treatments tested in this trial
- Acupuncture
- Attention control
Treatment groups
Sponsors and collaborators
University of California, Los Angeles
Lead sponsor
University of Illinois at Chicago
Collaborator
National Institute of Nursing Research (NINR)
Collaborator